NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
2.250
-0.130 (-5.46%)
At close: May 6, 2026, 4:00 PM EDT
2.290
+0.040 (1.78%)
After-hours: May 6, 2026, 7:55 PM EDT

NovaBridge Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-176.68-99.39-164.43-282.41-366.83
Depreciation & Amortization
0.070.260.480.212.29
Stock-Based Compensation
5.97-1.9510.2413.1595.75
Other Adjustments
44.631.5335.9361.1753.61
Change in Receivables
---1.5511.18
Changes in Inventories
-----4.29
Changes in Accrued Expenses
18.08-0.21-35.6818.3423.93
Changes in Unearned Revenue
----35.24
Changes in Other Operating Activities
-1.01-30.1-111.23-119.45-3.99
Operating Cash Flow
-20.6-52.67-72.7-49.58-153.1
Capital Expenditures
-0.01-0.05-0.16-2.09-4.71
Sale of Property, Plant & Equipment
0.050.06---
Purchases of Investments
-49.96-245.86-100-767.51-1,601
Proceeds from Sale of Investments
154.89109.8385764.421,492
Other Investing Activities
--22.2926.0873.22-0.94
Investing Cash Flow
104.97-136.02-15.16-5.18-114.41
Issuance of Common Stock
61.91-0.416.9294.99
Repurchase of Common Stock
--0.34-8.64-3.01-
Net Common Stock Issued (Repurchased)
61.91-0.34-8.243.9194.99
Other Financing Activities
-4.19-4.179.912.81-1.55
Financing Cash Flow
57.73-0.34-8.243.9193.44
Effect of Exchange Rate Changes on Cash and Cash Equivalents
0.280.575.214.2-20.26
Net Cash Flow
142.37-242.4-164.7-77.3-194.33
Free Cash Flow
-20.6-52.72-72.86-51.67-157.81
FCF Margin
---11528.60%3331.59%-1139.46%
Free Cash Flow Per Share
-0.22-0.65-0.88-0.63-2.08
Levered Free Cash Flow
-29.13-52.33-354.33-474.06-318.35
Unlevered Free Cash Flow
-77.13-81.52-218.62-156.04-277.85
Updated Apr 8, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q